Home » Subject » Page 5

Subject

US sanctions Chinese, Russian firms over Iran dealings

The US on Friday announced economic sanctions on Chinese and Russian companies that Washington said had supported the development of Iran’s missile program. The four firms, accused of “transferring sensitive technology and items to Iran’s missile program,” will be subject to restrictions on US government aid and on their exports for two years, Secretary of State Mike Pompeo said in a statement. The sanctions, imposed Wednesday, were against two Chinese-based companies, Chengdu Best New Materials and Zibo Elim Trade, as well as Russia-based Nilco Group and Joint Stock Company Elecon. “We will continue to work to impede Iran’s missile development efforts and use our sanctions authorities to spotlight the foreign suppliers, such as these entities in the PRC (China) and Russia, that provide mi...

Coronavirus vaccine breakthrough raises hopes of rapid global rollout

A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe. Early analysis of trials involving 20,000 volunteers in Britain and Brazil show the vaccine is at least 62% effective after two doses. In volunteers given a different dosing regimen — a half dose, followed by a full dose — that figure rose to 90%. The average efficacy of the two dosing methods is 70%. None of those given the vaccine developed severe COVID-19 illness. Andrew Pollard, director of the Oxford Vaccine Group, said the recent successful trials of three different vaccines by Oxford-AstraZeneca, Pfizer-BioNTech and Moderna, represent a...

  • 1
  • 4
  • 5